KASSIE STAFFORD: Open Payments
NPI 1245567775 · PASS CHRISTIAN, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,550 in 73 payments from 19 companies in 2025. Trend: 2023 $1,530 · 2024 $1,713 · 2025 $1,550
Food & beverage: $1,550
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 16 | $304 |
| ABBVIE INC. | 13 | $205 |
| Hill Dermaceuticals, Inc. | 1 | $149 |
| Novartis Pharmaceuticals Corporation | 5 | $105 |
| Regeneron Healthcare Solutions, Inc. | 5 | $101 |
| Galderma Laboratories, L.P. | 4 | $85 |
| E.R. Squibb & Sons, L.L.C. | 4 | $84 |
| UCB, Inc. | 3 | $80 |
| Amgen Inc. | 3 | $63 |
| Incyte Corporation | 3 | $62 |
Products named: DUPIXENT, SKYRIZI, Tolak, Sotyktu, Bimzelx, Otezla, OPZELURA, COSENTYX.
Industry payments across MS — which companies pay providers there.
